The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $95.03 million. The enterprise value is $74.91 million.
| Market Cap | 95.03M |
| Enterprise Value | 74.91M |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 13.61 million shares outstanding. The number of shares has decreased by -3.17% in one year.
| Current Share Class | 13.61M |
| Shares Outstanding | 13.61M |
| Shares Change (YoY) | -3.17% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 16.48% |
| Owned by Institutions (%) | 35.63% |
| Float | 6.53M |
Valuation Ratios
The trailing PE ratio is 26.83 and the forward PE ratio is 12.38.
| PE Ratio | 26.83 |
| Forward PE | 12.38 |
| PS Ratio | 1.63 |
| Forward PS | 1.54 |
| PB Ratio | 6.06 |
| P/TBV Ratio | 6.03 |
| P/FCF Ratio | 22.62 |
| P/OCF Ratio | 17.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.78, with an EV/FCF ratio of 17.86.
| EV / Earnings | 19.88 |
| EV / Sales | 1.29 |
| EV / EBITDA | 18.78 |
| EV / EBIT | 32.53 |
| EV / FCF | 17.86 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.83 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 0.48 |
| Interest Coverage | 1,532.63 |
Financial Efficiency
Return on equity (ROE) is 10.62% and return on invested capital (ROIC) is 6.70%.
| Return on Equity (ROE) | 10.62% |
| Return on Assets (ROA) | 2.33% |
| Return on Invested Capital (ROIC) | 6.70% |
| Return on Capital Employed (ROCE) | 8.40% |
| Weighted Average Cost of Capital (WACC) | 10.05% |
| Revenue Per Employee | $177,424 |
| Profits Per Employee | $11,510 |
| Employee Count | 330 |
| Asset Turnover | 0.94 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $34,079 in taxes.
| Income Tax | 34,079 |
| Effective Tax Rate | 1.61% |
Stock Price Statistics
The stock price has decreased by -16.80% in the last 52 weeks. The beta is 1.09, so The Joint's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -16.80% |
| 50-Day Moving Average | 8.03 |
| 200-Day Moving Average | 8.69 |
| Relative Strength Index (RSI) | 31.34 |
| Average Volume (20 Days) | 75,875 |
Short Selling Information
The latest short interest is 405,587, so 2.98% of the outstanding shares have been sold short.
| Short Interest | 405,587 |
| Short Previous Month | 439,478 |
| Short % of Shares Out | 2.98% |
| Short % of Float | 6.21% |
| Short Ratio (days to cover) | 4.35 |
Income Statement
In the last 12 months, The Joint had revenue of $58.55 million and earned $3.80 million in profits. Earnings per share was $0.26.
| Revenue | 58.55M |
| Gross Profit | 47.87M |
| Operating Income | 2.32M |
| Pretax Income | 2.11M |
| Net Income | 3.80M |
| EBITDA | 4.02M |
| EBIT | 2.32M |
| Earnings Per Share (EPS) | $0.26 |
Balance Sheet
The company has $22.16 million in cash and $2.04 million in debt, with a net cash position of $20.12 million or $1.48 per share.
| Cash & Cash Equivalents | 22.16M |
| Total Debt | 2.04M |
| Net Cash | 20.12M |
| Net Cash Per Share | $1.48 |
| Equity (Book Value) | 15.88M |
| Book Value Per Share | 1.16 |
| Working Capital | 19.82M |
Cash Flow
In the last 12 months, operating cash flow was $5.39 million and capital expenditures -$1.16 million, giving a free cash flow of $4.23 million.
| Operating Cash Flow | 5.39M |
| Capital Expenditures | -1.16M |
| Depreciation & Amortization | 1.70M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.23M |
| FCF Per Share | $0.31 |
Margins
Gross margin is 81.76%, with operating and profit margins of 3.97% and 6.49%.
| Gross Margin | 81.76% |
| Operating Margin | 3.97% |
| Pretax Margin | 3.61% |
| Profit Margin | 6.49% |
| EBITDA Margin | 6.87% |
| EBIT Margin | 3.97% |
| FCF Margin | 7.22% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.17% |
| Shareholder Yield | 3.17% |
| Earnings Yield | 3.97% |
| FCF Yield | 4.42% |
Analyst Forecast
The average price target for The Joint is $10.00, which is 43.16% higher than the current price. The consensus rating is "Hold".
| Price Target | $10.00 |
| Price Target Difference | 43.16% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.96% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 3.43 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.43 |
| Piotroski F-Score | 7 |